Edition:
United Kingdom

People: Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

25.80USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$25.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
325,136
52-wk High
$41.40
52-wk Low
$17.90

Collins, Cynthia 

Ms. Cynthia L. Collins is interim Chief Executive Officer, Director of the company. Ms. Collins is a recognized leader in cell and gene therapy, molecular diagnostics, life sciences, and therapeutics. Prior to her most recent position as CEO of Human Longevity, Inc., she served as the CEO/GM of General Electric's Healthcare Cell Therapy Business, Lab Businesses and Clarient Diagnostics. Prior to GE, Ms. Collins served as President and CEO of GenVec, a publicly-traded vaccine and gene therapy company and before that, she served as Group Vice President, Cellular Analysis Business of Beckman Coulter with responsibility for its Hematology, Flow Cytometry, and Hemostasis businesses. Earlier in her career, she served as President and CEO of Sequoia Pharmaceuticals, Inc., and as President of Clinical Micro Sensors, Inc., a wholly-owned subsidiary of Motorola. She also spent 17 years with Baxter Healthcare in a variety of executive roles, including as President of Oncology and as Vice President and General Manager of Cell Therapies. Ms. Collins began her career with Abbott Laboratories. Ms. Collins received her BS degree in Microbiology from the University of Illinois, Urbana, and her MBA from The University of Chicago Booth School of Business. She is also a member of the board of directors for the ARM Foundation for Cell and Gene Medicine, Triumvira Immunologics, DermTech, Cavidi, and Biocare Medical.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Mullen

--

Katrine Bosley

6,091,500

Cynthia Collins

--

Charles Albright

1,266,640

Gerald Cox

2,467,450

Andrew Hirsch

246,416
As Of  31 Dec 2017